Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental ...
An NIH advisor told researchers gathered at the American Diabetes Association conference that MAHA goals match the agency's ...
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect ...
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...
The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...
For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might ...
NEW YORK — The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread, according to a new analysis by U.S. health ...
A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with ...
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion ...
Biomedical researchers and policy experts decried the change when it was proposed this spring. STAT’s Anil Oza has the latest ...
Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results